CA184-161: A phase I/II trial of vemurafenib and ipilimumab in patients with BRAF V600 mutation-positive metastatic melanoma Meeting Abstract
| Authors: | Ribas, A.; Hodi, F. S.; Kurland, J. F.; Shahabi, V.; Francis, S.; Konto, C.; Joe, A. K.; Lainas, I.; Wolchok, J. D. |
| Abstract Title: | CA184-161: A phase I/II trial of vemurafenib and ipilimumab in patients with BRAF V600 mutation-positive metastatic melanoma |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009801483 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.TPS8603 |
| Notes: | Meeting Abstract: TPS8603 -- Source: Wos |
